Metraipolis › archive › dc_2c7ebadce0cf

Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies — Europe PMC PMID:40943541

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943541
DOI
10.3390/ijms26178624
License (as archived)
solo-consultazione
Archived
2026-11-10T02:57:23.252Z
SHA-256 of the archived text
daa5ffcf6f029fd7fbc6c023abdaafc40503e2d5de64c64f6b89987a84e6f949
Stable URL of this page
https://metraipolis.com/documento/dc_2c7ebadce0cf

How to cite

Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies — Europe PMC PMID:40943541 — Europe PMC (en), https://europepmc.org/article/MED/40943541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c7ebadce0cf (Metraipolis archive dc_2c7ebadce0cf, sha256 daa5ffcf6f029fd7fbc6c023abdaafc40503e2d5de64c64f6b89987a84e6f949)
BibTeX
@misc{dc2c7ebadce0cf,
  title = {Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies — Europe PMC PMID:40943541},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943541},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c7ebadce0cf; sha256 daa5ffcf6f029fd7fbc6c023abdaafc40503e2d5de64c64f6b89987a84e6f949},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943541. Agents can read the archived copy with the MCP tool read_document.